150 results
Page 3 of 8
6-K
EX-1.1
a57dq6mx fnm5c
12 Oct 22
Current report (foreign)
4:02pm
6-K
EX-1.1
lcgui4iwodvebsan
30 Sep 22
Current report (foreign)
4:02pm
6-K
EX-1.1
g763lt zy3
14 Sep 22
Current report (foreign)
4:06pm
6-K
EX-1.1
ewfnx
10 Aug 22
Current report (foreign)
4:18pm
6-K
h6uooo8b4bvczjlbd
10 Aug 22
Current report (foreign)
4:13pm
6-K
EX-1.1
z7lobhbxkoq44d
13 Jul 22
Current report (foreign)
5:04pm
6-K
EX-1.1
i7chv3f9
30 Jun 22
Current report (foreign)
4:01pm
6-K
EX-1.1
2v26t6x
15 Jun 22
Current report (foreign)
4:03pm
6-K
EX-1.1
r9hz94 krdnuz488zl4i
2 Jun 22
Current report (foreign)
4:01pm
6-K
EX-1.1
1ob zm3pg
11 May 22
Current report (foreign)
4:14pm
6-K
EX-99.2
7hsy4dx2iz
11 May 22
Current report (foreign)
4:06pm
6-K
EX-99.2
2ye75 zgj4388bpyesq
2 May 22
Notice to convene Annual General Meeting 2022
6:25am
6-K
EX-99.3
cxznj7kjj7rhoej gj
2 May 22
Notice to convene Annual General Meeting 2022
6:25am
6-K
EX-1.1
61sli73fql7w1n6hh1
13 Apr 22
Current report (foreign)
4:12pm
6-K
EX-1.1
bisek1ch 9v4mp
31 Mar 22
Current report (foreign)
5:53pm
6-K
EX-4.1
hs0qk78o
29 Mar 22
Ascendis Pharma Announces Proposed Convertible Senior Notes Offering
5:01pm
6-K
EX-1.1
0ep utxjz4qa1
29 Mar 22
Ascendis Pharma Announces Proposed Convertible Senior Notes Offering
5:01pm